GNH USA

Europe — EMA

Normostop (Dimenhydrinate)

GNH USA supplies Normostop (Dimenhydrinate), a first‑generation antihistamine for motion sickness, vertigo and nausea. Request a quote for global supply.

Request sourcing

1
Pack/s

What is Dimenhydrinate?

Dimenhydrinate, the active ingredient in Normostop, is a first‑generation antihistamine presented as an oral tablet for oral use. It treats motion‑induced nausea, vertigo and other causes of nausea and vomiting in adults and children.

GNH USA supplies Normostop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Dimenhydrinate used for?

Dimenhydrinate is a first‑generation antihistamine used to manage vestibular and gastrointestinal disturbances.

- Motion sickness: reduces nausea, vomiting and dizziness associated with travel. - Vertigo: alleviates dizziness caused by vestibular disorders. - Nausea and vomiting: controls symptoms from various causes such as gastrointestinal upset or medication side effects.

What are the side effects of Dimenhydrinate?

Dimenhydrinate may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to a sticky sensation. - Blurred vision: temporary difficulty focusing. - Constipation: slowed intestinal motility. - Headache: mild to moderate cranial pain. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, swelling of face or throat. - Tachycardia: unusually rapid heart rate. - Confusion or agitation: altered mental status. - Urinary retention: difficulty emptying the bladder. - Severe hypotension: marked drop in blood pressure. - Anaphylaxis: life‑threatening systemic allergic response.

What precautions apply to Dimenhydrinate?

Before using Dimenhydrinate, consider the following safety measures.

- Use in children: follow prescriber guidance and age‑appropriate dosing. - Avoid alcohol: may intensify sedation and dizziness. - Caution in glaucoma: anticholinergic effect can increase intra‑ocular pressure. - Elderly patients: higher risk of falls and anticholinergic side effects. - Pregnancy and lactation: safety not established; consult a healthcare professional. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

What does Dimenhydrinate interact with?

Dimenhydrinate can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Alcohol and other central nervous system depressants: may cause excessive sedation. - Monoamine oxidase inhibitors (MAOIs): risk of heightened anticholinergic effects. - Other antihistamines or anticholinergic agents: additive sedation and dry‑mouth.

Moderate Interactions (Monitor Closely): - Tricyclic antidepressants: may increase anticholinergic burden. - Antihypertensive drugs: potential for additive blood‑pressure lowering effects.

Frequently asked questions

What conditions is Normostop used to treat?+
Normostop contains dimenhydrinate and is indicated for the prevention and treatment of motion sickness, vertigo, and nausea or vomiting caused by various triggers. It helps reduce the sensation of dizziness and the urge to vomit during travel, vestibular disturbances, or other situations that provoke these symptoms.
How does dimenhydrinate work in the body?+
Dimenhydrinate blocks histamine H1 receptors in the brain’s vestibular system and the vomiting centre, which reduces the signal that triggers nausea. Its anticholinergic activity also dampens central pathways involved in emesis, providing relief from motion‑related and other types of nausea.
What is the usual dose of Normostop?+
The appropriate dose of Normostop is determined by a qualified prescriber based on the patient’s age, weight, medical condition and response to therapy. Healthcare professionals tailor the regimen to achieve optimal symptom control while minimizing potential side effects.
Is Normostop safe to use during pregnancy or breastfeeding?+
Safety data for dimenhydrinate in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Normostop.
How do I order Normostop from GNH USA?+
To request Normostop, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Normostop compare with other anti‑motion‑sickness drugs?+
Normostop (dimenhydrinate) is a first‑generation antihistamine, whereas alternatives such as meclizine or scopolamine belong to different classes. Dimenhydrinate offers rapid onset and is widely available OTC, but it may cause more drowsiness compared with newer agents. Choice of therapy depends on efficacy, side‑effect profile and individual patient factors.
What are the recommended storage conditions for Normostop?+
Normostop should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain its stability and potency throughout its shelf life.
How is Normostop administered?+
Normostop is taken orally, usually as a tablet, with or without food as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.
What are the most serious risks associated with Normostop?+
Serious adverse reactions, although rare, can include severe allergic responses such as rash, swelling, or anaphylaxis, as well as tachycardia, marked hypotension, confusion, urinary retention, and profound sedation. Patients should seek immediate medical attention if any of these symptoms develop.
Who should avoid using Normostop?+
Normostop should not be used by individuals with known hypersensitivity to dimenhydrinate or other first‑generation antihistamines. Caution is advised for patients with glaucoma, enlarged prostate, severe asthma, or those taking other anticholinergic or sedating medications. Pregnant or breastfeeding women should consult a physician before use.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Dimenhydrinate
Route
Oral Use
Manufacturer
Laboratorios Normon, S.A.
Origin
EU

Related products